CYTK vs KYMR
Cytokinetics, Incorporated · Kymera Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | CYTK | KYMR |
|---|---|---|
| Price | $72.09 | $118.15 |
| Market Cap | $8.97B | $9.72B |
| P/E | — | — |
| P/B | — | 6.31 |
| P/S | 101.89 | 247.86 |
| ROE | — | -20.2% |
| Net Margin | -891.6% | -794.0% |
| Gross Margin | — | — |
| Revenue Growth | 376.6% | -16.7% |
| Dividend Yield | — | — |
| EPS | -$6.31 | -$3.79 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.